BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9539656)

  • 1. Fecal lysozyme in assessment of disease activity in inflammatory bowel disease.
    van der Sluys Veer A; Brouwer J; Biemond I; Bohbouth GE; Verspaget HW; Lamers CB
    Dig Dis Sci; 1998 Mar; 43(3):590-5. PubMed ID: 9539656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lysozyme levels in chronic inflammatory bowel diseases (author's transl)].
    Röllinghoff W; Brandes JW; Ehms H; Miller B; Schmülling RM; Tischendorf FW; Malchow H
    Klin Wochenschr; 1977 Mar; 55(5):225-30. PubMed ID: 846183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neopterin concentration as an index of disease activity in Crohn's disease and ulcerative colitis.
    Husain N; Tokoro K; Popov JM; Naides SJ; Kwasny MJ; Buchman AL
    J Clin Gastroenterol; 2013 Mar; 47(3):246-51. PubMed ID: 23269308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muramidase (lysozyme) in Crohn's disease and in ulcerative colitis.
    Pruzanski W; Marcon N; Ottaway C; Prokipchuk E
    Am J Dig Dis; 1977 Nov; 22(11):995-8. PubMed ID: 920710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lysozyme in Crohn's disease and ulcerative colitis.
    Falchuk KR; Perrotto JL; Isselbacher KJ
    N Engl J Med; 1975 Feb; 292(8):395-7. PubMed ID: 1110725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora.
    Swidsinski A; Loening-Baucke V; Vaneechoutte M; Doerffel Y
    Inflamm Bowel Dis; 2008 Feb; 14(2):147-61. PubMed ID: 18050295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum lysozyme levels in Crohn's disease and ulcerative colitis.
    Peeters TL; Vantrappen G; Geboes K
    Gut; 1976 Apr; 17(4):300-5. PubMed ID: 773792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lysozyme in inflammatory bowel disease.
    Nugent FW; Mallari R; George H; Ridley N
    Gastroenterology; 1976 Jun; 70(6):1014-6. PubMed ID: 1269861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of fecal calprotectin for the prediction of endoscopic activity in patients with inflammatory bowel disease.
    Jusué V; Chaparro M; Gisbert JP
    Dig Liver Dis; 2018 Apr; 50(4):353-359. PubMed ID: 29396129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PMN-elastase in assessment of patients with inflammatory bowel disease.
    Andus T; Gross V; Caesar I; Krumm D; Hosp J; Gerok W; Schölmerich J
    Dig Dis Sci; 1993 Sep; 38(9):1638-44. PubMed ID: 8359075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and faecal lysozyme in inflammatory bowel disease.
    Klass HJ; Neale G
    Gut; 1978 Mar; 19(3):233-9. PubMed ID: 631644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lysozyme in Crohn's disease and ulcerative colitis.
    Helman CA; Novis BH; Bank S; Wormold L; Jacobs P
    S Afr Med J; 1977 Dec; 52(26):1042-4. PubMed ID: 609977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of a rapid fecal latex agglutination test detecting the neutrophil protein, lactoferrin, for diagnosing inflammatory causes of chronic diarrhea.
    Fine KD; Ogunji F; George J; Niehaus MD; Guerrant RL
    Am J Gastroenterol; 1998 Aug; 93(8):1300-5. PubMed ID: 9707055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual fecal alpha 1-antitrypsin excretion reflects clinical activity in Crohn's disease but not in ulcerative colitis.
    Becker K; Berger M; Niederau C; Frieling T
    Hepatogastroenterology; 1999; 46(28):2309-14. PubMed ID: 10521988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lysozyme in inflammatory bowel and coeliac disease.
    Mallas E; Terry JM; Asquith P; Cooke WT
    J Clin Pathol; 1976 Jul; 29(7):598-600. PubMed ID: 977770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lysozyme in Crohn's disease and ulcerative colitis.
    Hylander E; Hansen NE; Karle H; Janrum S
    Scand J Gastroenterol; 1976; 11(2):213-7. PubMed ID: 1265442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic value of serum lysozyme activity in inflammatory bowel disease.
    Ayulo JA; Chen CC; Pelot D; Berk JE
    Am J Gastroenterol; 1977 Jul; 68(1):71-6. PubMed ID: 910787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease.
    Becker K; Niederau C; Frieling T
    Z Gastroenterol; 1999 Jul; 37(7):597-605. PubMed ID: 10458008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
    García-Sánchez V; Iglesias-Flores E; González R; Gisbert JP; Gallardo-Valverde JM; González-Galilea A; Naranjo-Rodríguez A; de Dios-Vega JF; Muntané J; Gómez-Camacho F
    J Crohns Colitis; 2010 Jun; 4(2):144-52. PubMed ID: 21122498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: Serum lysozyme levels in Crohn's disease and ulcerative colitis.
    Hylander E; Hansen NE; Karle H; Jarnum S
    N Engl J Med; 1976 Jan; 294(2):111. PubMed ID: 1244493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.